Neurodivergence

WURS-61: Wender Utah Rating Scale

Retrospective childhood ADHD assessment. Adults rate symptoms from ages 5–10 to establish the early onset required for a DSM-5-TR ADHD diagnosis.

Foundational Context

Developed by Ward, Wender, and Reimherr (1993), the Wender Utah Rating Scale (WURS) was created to evaluate childhood behaviors associated with ADHD in adults. It supports the DSM-5-TR requirement that ADHD symptoms were present before age 12.

The WURS is unique in its focus on the "Utah Criteria" for ADHD, which includes emotional dysregulation and mood lability in addition to classic core symptoms of inattention and hyperactivity.

What the Assessment Measures

The full WURS-61 consists of 61 retrospective items. However, clinical scoring typically uses a specific subset of 25 items (the WURS-25). Adults rate how they experienced symptoms during childhood (approximately ages 5–10) on a 5-point scale (0 = Not at all/Slightly to 4 = Very much).

Core Childhood Symptom Domains:

  • Attention & Concentration: Trouble concentrating, daydreaming, difficulty completing work.
  • Impulsivity: Acting before thinking, getting into trouble, impulsive planning.
  • Behavior & Conduct: Fighting with children, being rebellious, trouble at school.
  • Academic & Learning: Trouble with reading or arithmetic, underachieving.
  • Emotional Dysregulation: Moody, irritability, hot temper, low frustration tolerance.

Interpretation Guidelines

Sum only the 25 WURS-25 items for the clinical score (maximum 100).

  • 0–24: Not consistent with childhood ADHD.
  • 25–45: Borderline, clinical judgment required. Consider collateral history.
  • ≥36: Elevated, higher sensitivity cutoff (used in some settings).
  • ≥46: Consistent with childhood ADHD. Validated threshold achieving 86% sensitivity and 99% specificity vs. depressed adults (Ward et al., 1993).

Important: The WURS establishes childhood onset; the ASRS (Adult ADHD Self-Report Scale) should be used to screen for current symptoms.

Administration Considerations

  1. Format: Self-administered, typically 10 minutes.
  2. Instructions: Rate symptoms based on childhood experience (ages 5–10) only.
  3. Scoring: Sum only the designated 25 items for the WURS-25 total.
  4. Integration: Best used alongside the ASRS. Corroborate with childhood records or parent reports where possible.

Psychometric Properties

  • Internal consistency: Cronbach’s α ≈ 0.94.
  • Sensitivity: 86% (at cutoff ≥ 46).
  • Specificity: 99% (at cutoff ≥ 46 vs. depressed adults).
  • Validation: Ward et al. (1993).

Limitations

  • Recall Bias: Current mood (especially depression) can distort retrospective reporting.
  • Not Diagnostic Alone: Requires a full clinical interview and collateral history.
  • Utah Criteria: Some items may not map directly to current DSM-5-TR ADHD symptom descriptions.

References

Ward, M. F., Wender, P. H., & Reimherr, F. W. (1993). The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. American Journal of Psychiatry, 150(6), 885-890.

Additional Context

Retrospective self-report scale for assessing childhood ADHD symptoms in adults. Establishes the early onset required for a DSM-5-TR ADHD diagnosis.

WURS-61 vs WURS-25

The full 61-item scale vs the 25-item validated scoring subset

The full scale

The complete 61-item questionnaire administered to the patient. Covers all childhood symptom domains including attention, impulsivity, conduct, academics, and mood. Provides full clinical context but is not used in its entirety for scoring.

The validated scoring subset

A specific subset of 25 items drawn from the full scale. These 25 items are summed for the clinical score (range 0–100). The WURS-25 cutoff of ≥46 is the validated threshold from Ward et al. (1993) and is what clinicians mean when referencing "WURS scoring."

When clinicians say "WURS score" they mean WURS-25

WURS-25 Scoring Guide

Each of the 25 scored items is rated 0–4. Maximum score: 100.

Scoring note: The rating scale is 0 = Not at all or Slightly, 1 = Mildly, 2 = Moderately, 3 = Quite a bit, 4 = Very much. Sum only the 25 designated WURS-25 items. The remaining 36 items are not included in the scored total but may be reviewed clinically.

Five Childhood Symptom Domains

The WURS-61 assesses retrospective childhood symptoms across five core areas.

WURS-61 vs ASRS: Using Both Together

These two tools measure different time frames and together support a full adult ADHD evaluation

Recommended Workflow

Administer the ASRS at intake to screen for current ADHD symptoms. If Part A is positive (4+ responses), follow up with the WURS-61 to assess childhood onset. A positive ASRS combined with a WURS-25 score ≥46 provides the strongest support for an adult ADHD diagnosis, satisfying both the current impairment and childhood onset criteria in DSM-5-TR.

Administration & Limitations

Administration

  • Self-administered, typically 10 minutes
  • Complete before or during clinical intake
  • Rate symptoms from approximately ages 5–10
  • Public domain, no licensing required
  • Validated in English, Dutch, Italian, Spanish

Key Limitations

  • Recall bias: Current mood (especially depression) can distort retrospective reporting
  • No diagnosis alone: WURS is a screening aid, diagnosis requires clinical interview and collateral history
  • Utah criteria: Based on pre-DSM-5-TR Utah criteria; some items do not map directly to current DSM-5-TR ADHD symptom descriptions
  • Corroborate when possible: Childhood records, parent/sibling informants strengthen validity

Documenting WURS-61 results in clinical notes?

Record the WURS-25 total score in the Objective section of your note, with the interpretation (e.g., "WURS-25: 52, consistent with childhood ADHD onset"). See our SOAP notes guide and intake notes guide for templates and examples.

ADHD and related tools commonly used alongside WURS-61

Automate WURS-61 in Your Clinic

HiBoop delivers WURS-61 and ASRS together as a linked intake protocol, automated scoring, longitudinal tracking, and DSM-5-TR childhood onset documentation in one workflow.

Clinical Use:These results are intended to inform clinical decision-making in licensed practice. They do not replace evaluation by a qualified clinician.